Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Audeara.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX healthcare sector Christmas rally runs out of puff
Tech
ASX Tech Stocks: PlaySide Studios set to develop mixed reality game for Meta
News
Top 10 at 10: Big gold, rare earths hits have ASX stocks riding high
News
LAST ORDERS: A short treatise on the cavalcade of whimsy from the ASX and elsewhere today
Experts
ScoPo’s Powerplays: ASX health stocks catch a strong bid in July rally
Tech
Best results yet: Audeara smashes quarterly sales records, up 175% PCP
Experts
ScoPo’s Powerplays: ASX health stocks up for second week, investors get reason to smile
Experts
ScoPo’s Powerplays: Much needed July rally for beaten-down ASX health stocks
Tech
Global retail deal with Amplifon has Audeara shouting from on top of the world
Experts
ScoPo’s Powerplays: ASX health stocks offer bargains galore during tax time sell down
Health & Biotech
Primed for growth: Audeara increases sales channels by 20% by partnering with optometry giant Specsavers
News
Top 10 at 10: Which ASX stocks are flying on Friday?
Experts
ScoPo’s Powerplays: Health stocks bounce up and down as markets tumble
Tech
HealthKick Podcast: Audeara’s revenue up nearly 140pc YoY… and 50pc from the previous quarter
Health & Biotech
Morgans: This incredible Aussie medtech is trading at just ⅓ its real value
Health & Biotech
ScoPo’s Powerplays: All we want for Christmas is a market rally
Tech
